Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: An overview

Expert Opinion on Drug Delivery

Volumn 9, Issue 8, 2012, Pages 953-974

  Shakeel, Faiyaz ^a   Shafiq, Sheikh ^b   Haq, Nazrul ^a   Alanazi, Fars K ^a,c   Alsarra, Ibrahim A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ZYDUS RESEARCH CENTRE   (India)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Dermal delivery; Drug delivery vehicles; Hydrophobic compounds; Nanoemulsions; Transdermal delivery

Indexed keywords

ACECLOFAR; ACECLOFENAC; AMINOLEVULINIC ACID; AMPRENAVIR; CELECOXIB; CLOBETASOL PROPIONATE; CURCUMIN; CYCLOSPORIN A; CYPROTERONE ACETATE; DICLOFENAC; ESTRADIOL; FINASTERIDE; FLEXOGAN; FLUDROCORTISONE ACETATE; FLUMETASONE; GENISTEIN; INDOBENE; INDOMETACIN; KETOPROFEN; NABUMETONE; NIMESULIDE; OXALGINNANOGEL; PREDNICARBATE; PROGESTERONE; QUERCETIN; QUERCETIN 3 METHYL ETHER; RITONAVIR; SALICYLIC ACID METHYL ESTER; SAQUINAVIR; TEMOPORFIN; THIOCTIC ACID; TOCOPHEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHOPHYLL;

ANTIINFLAMMATORY ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; HUMAN; HYDROGEL; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MICROEMULSION; NANOEMULSION; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; RICE BRAN; SKIN IRRITATION; SKIN PERMEABILITY; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EMULSIONS; EXCIPIENTS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; SKIN; SKIN ABSORPTION; SURFACE PROPERTIES;

EID: 84864201376     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.696605     Document Type: Review

References (96)

1. Santos P, Watkinson AC, Hadgraft J, et al. Application of microemulsions in dermal and transdermal drug delivery. Skin Pharmacol Physiol 2008;21:246-59
2. Gattu S, Maibach HI. Enhanced absorption through damaged skin: An overview of the in vitro human model. Skin Pharmacol Physiol 2010;23:173-176
3. Lipinski C. Poor aqueous solubility - an industry wide problem in drug discovery. Am Pharm Rev 2002;5:82-5
4. Kommuru TRK, Gurley B, Khan MA, et al. Selfemulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm 2001;212:233-46
5. Vyas A, Saraf S, Saraf S. Cyclodextrin based novel drug delivery system. J Inc Phenom Macrocyc Chem 2008;62:23-42
6. Shakeel F, Faisal MS. Caffeine: A potential complexing agent for solubility and dissolution enhancement of celecoxib. Pharm Biol 2010;48:113-15
7. Serajuddin AT. Salt formation to improve drug solubility. Adv Drug Deliv Rev 2007;59:603-16
8. Gupta U, Agashe HB, Asthana A, et al. Dendrimers: Novel polymeric nanoartchitectures for solubility enhancement. Biomacromolecules 2006;7:649-58
9. Akers MJ. Excipient-drug interactions in parenteral formulations. J Pharm Sci 2002;91:2283-300
10. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201-30
11. Shakeel F, Baboota S, Ahuja A, et al. Celecoxib nanoemulsion: Skin permeation mechanism and bioavailability assessment. J Drug Target 2008;16:733-40
12. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption and biopharmaceutical aspects. Pharm Res 1995;12:1561-72
13. Marcato PD, Duran N. New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol 2008;8:2216-29
14. Riehemann K, Schneider SW, Luger TA, et al. Nanomedicine: Challenge and perspectives. Angew Chem Int Ed Engl 2009;48:872-97
15. Junghanns JUAH, Muller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 2008;3:295-309
16. Thakur R, Anwer MK, Shams MS, et al. Proniosomal transdermal therapeutic system of losartan potassium: Development and pharmacokinetic evaluation. J Drug Target 2009;17:442-9
17. He S, Zhu J, Xie F. Preparation and characterization of tramadol PEG- coated multivesicular liposomes for sustained release. Pharmazie 2010;65:467-70
18. Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227-43
19. Shafiq S, Shakeel F, Talegaonkar S, et al. Design and development of ramipril nanoemulsion formulation: In vitro and in vivo assessment. J Biomed Nanotechnol 2007;3:28-44
20. Shafiq S, Shakeel F, Talegaonkar S, et al. Formulation development and optimazation using nanoemulsion technique: A technical note. AAPS Pharm Sci Tech 2007;8:E28
21. Anton N, Vandamme TF. Nanoemulsions and microemulsions: Clarification of critical differences. Pharm Res 2011;28:978-85
22. McClements DJ. Nanoemulsions versus microemulsions: Terminology, differences and similarities. Soft Matter 2012;8:1719-29
23. Rao JJ, McClements DJ. Lemon oil solubilization in mixed surfactant solutions: Rationalizing microemulsion & nanoemulsion formation. Food Hydrocoll 2012;26:268-76
24. Shakeel F, Ramadan W, Faisal MS, et al. Transdermal and topical delivery of anti-inflammatory agents using nanoemulsion/microemulsion: An updated review. Curr Nanosci 2010;6:184-98
25. Shafiq S, Shakeel F. Enhanced stability of ramipril in nanoemulsion containing Cremophor-EL: A technical note. AAPS Pharm Sci Tech 2008;9:1097-01
26. Anton N, Gayet P, Benoit JP, et al. Nanoemulsions and nanocapsules by PIT methods: An investigation on the role of temperature cycling on the emulsion phase inversion. Int J Pharm 2007;344:44-52
27. Bawarski WE, Chidlowsky E, Bharali DJ, et al. Emerging nanopharmaceuticals. Nanomedicine 2008;4:273-82
28. Sanjula B, Shah FM, Javed A, et al. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target 2009;17:249-56
29. Mayer C. Nanocapsules as drug delivery systems. Int J Artif Organs 2005;28:1163-71
30. Ahad A, Aqil M, Kohli K, et al. Formulation and optimization of nanotransferosomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine 2012;8:237-49
31. Azeem A, Anwer MK, Talegaokar S. Niosomes in sustained and targeted drug delivery: Some recent advances. J Drug Target 2009;17:671-89
32. Kim S, Shi Y, Kim JY, et al. Overcoming the barriers in micellar drug delivery: Loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin Drug Deliv 2010;7:49-62
33. Jafari SM, He Y, Bhandari B. Optimization of nanoemulsion production by microfluidization. Eur Food Res Technol 2007;225:733-41
34. Kentish S, Wooster TJ, Ashokkumar M, et al. The use of ultrasonics for nanoemulsion preparation. Innvot Food Sci Emerg Technol 2008;9:170-5
35. Rosano HL, Cavello JL, Lyons GB. Mechanism of formation of six microemulsion systems. In: Rosano HL, Clausse M, editors. Microemulsion systems. Marcel Dekker, Inc.; New York: 1987. p. 259
36. Shinoda K, Araki M, Sadaghiani A, et al. Lecithin-based microemulsions: Phase behaviour and microstructure. J Phys Chem 1991;95:989-93
37. Dokka S, Cooper SR, Kelly S, et al. Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin. J Invest Dermatol 2005;124:971-5
38. Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today 2005;2:67-74
39. Mitri K, Shegokar R, Gohla S, et al. Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance. Int J Pharm 2011;414:267-75
40. Mahdi ES, Noor AM, Hameem M, et al. Formulation and in vitro release evaluation of newly synthesized palm kernel oil esters based-nanoemulsion delivery system for 30% dried ethanolic extract derived from local Phyllanthus urinaria for skin aging. Int J Nanomed 2011;6:2499-12
41. Bernardi DS, Pereira TA, Maciel NR, et al. Formulation and stability of oil-in-water nanoemulsions containing rice bran oil: In vitro and in vivo assessments. J Nanobiotechnol 2011;9:E44
42. Fontana MC, Rezer JFP, Coradini K, et al. Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate. Eur J Pharm Biopharm 2011;79:241-9
43. Biruss B, Kahlig H, Valenta C. Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones. Int J Pharm 2007;328:142-51
44. Klang V, Haberfeld S, Hartl A, et al. Effect of gamma-cyclodextrin on the in vitro skin permeation of a steroidal drug from nanoemulsions: Impact of experimental setup. Int J Pharm 2012;423:535-42
45. Sakeena MHF, Muthanna FA, Ghassan ZA, et al. Formulation and in vitro evaluation of ketoprofen in palm oil esters nanoemulsion. J Oleo Sci 2010;59:223-8
46. Sakeena MHF, Yam MF, Elrashid SM, et al. Anti-inflammatory and analgesic effects of ketoprofen in palm oil esters nanoemulsion. J Oleo Sci 2010;59:667-71
47. Mou D, Chen H, Du D, et al. Hydrogel thickened nanoemulsion system for topical delivery of lipophilic drugs. Int J Pharm 2008;353:270-6
48. Baspinar Y, Keck CM, Borchert HH. Development of positively charged prednicarbate nanoemulsions. Int J Pharm 2010;383:201-8
49. Primo FL, Michieleto L, Rodrigues MAM, et al. Magnetic nanoemulsions as drug delivery system for Foscan-: Skin permeation and retention in vitro assays for topical application in photodynamic therapy (PDT) of skin cancer. J Mag Mag Mater 2007;311:354-7
50. Primo FL, Bentley MV, Tedesco AC. Photophysical studies and in vitro skin permeation/retention of Foscan/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment. J Nanosci Nanotechnol 2008;8:340-7
51. Primo FL, Dacosta-Reis MB, Porcionatto MA, et al. In vitro evaluation of chloroaluminium phthalocyanine nanoemulsion and low level laser therapy on human skin dermal equivalents and bone marrow mesenchymal stem cells. Curr Med Chem 2011;18:3376-81
52. Aubrun OS, Simonnet JT, Alloret FL. Nanoemulsions: A new vehicle for skincare products. Adv Colloid Interface Sci 2004;108:145-9
53. Deli G, Hatziantoniou S, Nikas Y, et al. Solid lipid nanoparticles and nanoemulsions containing ceramides: Preparation and physicochemical characterization. J Liposome Res 2009;19:180-8
54. Silva AP, Nunes BR, De-Oliveira MC, et al. Development of topical nanoemulsions containing isoflavone genistein. Pharmazie 2009;64:32-5
55. Ruktanonchai U, Beirapha P, Sakulkhu U, et al. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three nanoparticulate formulations of alpha lipoic acid. AAPS Pharm Sci Tech 2009;10:227-34
56. Fasolo D, Bassani VL, Teixeira HF. Development of topical nanoemulsions containing quercetin and 3-O-methylquercetin. Pharmazie 2009;64:726-30
57. Butnariu MV, Giuchici CV. The use of some nanoemulsion based on aqueous propolis and lycopene extract in the skin's protective mechanisms against UVA radiation. J Nanobiotechnol 2011;9:E3
58. Gholam P, Weberschock T, Denk K, et al. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis. Dermatology 2011;222:358-62
59. Wang X, Jiang Y, Wang YW, et al. Enhancing anti-inflammatory activity of curcumin through o/w nanoemulsions. Food Chem 2008;108:419-24
60. Khandavilli S, Panchagnula R. Nanoemulsions as versatile formulations for paclitaxel delivery: Peroral and dermal delivery studies in rats. J Invest Dermatol 2007;127:154-62
61. Hamouda T, Myc A, Donovan B, et al. A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol Res 2001;156:1-7
62. Kuo F, Subramanian B, Kotyla T, et al. Nanoemulsions of an antioxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties. Int J Pharm 2008;363:206-13
63. Zhang Y, Gao J, Zheng H, et al. The preparation of 3, 5 dihydroxy-4-isopropylstilbene nanoemulsion and in vitro release. Int J Nanomed 2011;6:649-57
64. Spagnul A, Bouvier-Capely C, Phan G, et al. A new formulation containing calixarene molecules as an emergency treatment of uranium skin contamination. Health Phys 2010;99:430-4
65. Spagnul A, Bouvier-Capely C, Phan G, et al. Ex vivo decrease in uranium diffusion through intact excoriated pig ear skin by a calixarene nanoemulsion. Eur J Pharm Biopharm 2011;79:258-67
66. Shakeel F, Baboota S, Ahuja A, et al. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharm Sci Tech 2007;8:E104
67. Shakeel F, Baboota S, Ahuja A, et al. Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation. Pharmazie 2008;63:580-4
68. Shakeel F, Faisal MS, Shafiq S. Comparative pharmacokinetic profile of aceclofenac from oral and transdermal application. J Bioeq Bioavail 2009;1:13-17
69. Shakeel F. Baboota S. Ahuja A. et al. Skin permeation and bioavailability enhancement of celecoxib by transdermally applied nanoemulsion J. Nanobiotechnol. 2008 6 E8.
70. Shakeel F, Baboota S, Ahuja A, et al. Celecoxib nanoemulsion for transdermal drug delivery: Characterization and in vitro evaluation. J Dispersion Sci Technol 2009;30:834-42
71. Shakeel F, Baboota S, Ahuja A, et al. Enhanced anti-inflammatory effects of celecoxib from transdermally applied nanoemulsion. Pharmazie 2009;64:258-9
72. Shakeel F, Ramadan W, Ahmed MA. Investigation of true nanoemulsions for transdermal potential of indomethacin: Characterization, rheological characteristics and ex vivo skin permeation studies. J Drug Target 2009;17:435-41
73. Shakeel F, Ramadan W, Gargum HM, et al. Preparation and in vivo evaluation of indomethacin loaded true nanoemulsions. Sci Pharm 2010;78:47-56
74. Baboota S, Shakeel F, Ahuja A, et al. Design development and evaluation of novel nanoemulsions formulations for transdermal potential of celecoxib. Acta Pharm 2007;57:315-32
75. Li Z, Peng-Wei Z, Feng SHI, et al. Preparation and transdermal permeation of capsaicin nanoemulsions on rats. China Pharm 2009;12:34
76. Hoeller S, Sperger A, Valenta C. Lecithin-based nanoemulsions: A comparative study of the influence of nonionic surfactants and the cationic phytosphingosine on physicochemical behavior and skin permeation. Int J Pharm 2009;370:181-6
77. Klang V, Matsko N, Zimmermann AM, et al. Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions. Int J Pharm 2010;393:152-60
78. Kim BS, Won M, Lee KM, et al. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Drug Deliv 2008;15:465-9
79. Sakeena MHF, Elrashid SM, Muthanna FA, et al. Effect of limonene on permeation enhancement of ketoprofen in palm oil esters nanoemulsion. J Oleo Sci 2010;59:395-400
80. Madhusudhan B, Rambhau D, Apte SS, et al. Improved in vitro permeation of nabumetone across rat skin from 1-Oalkylglycerol/lecithin stabilized o/w nanoemulsions. J Dispos Sci Technol 2006;27:921-6
81. Alves PM, Pohlmann AR, Guterres SS. Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsions: Development and rheological characterization. Pharmazie 2005;62:900-4
82. Alves MP, Scarrone AL, Santos M, et al. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 2007;341:215-20
83. Kumar D, Aqil M, Rizwan M, et al. Investigation of a nanoemulsion as vehicle for transdermal delivery of amlodipine. Pharmazie 2009;64:80-5
84. Dixit N, Kohli K, Baboota S. Nanoemulsion system for transdermal delivery of a poorly soluble cardiovascular drug. PDA J Pharm Sci Technol 2008;62:46-55
85. Akhter S, Jain GK, Ahmad FJ, et al. Investigation of nanoemulsion system for transdermal delivery of domperidone: Ex vivo and in vivo studies. Curr Nanosci 2008;4:381-90
86. Azeem A, Ahmad FJ, Khar RK, et al. Nanocarriers for transdermal delivery of an antiparkinsonian drug. AAPS Pharm Sci Tech 2009;10:1093-103
87. Azeem A, Talegaonkar S, Negi LM, et al. Oil based nanocarrier system for transdermal delivery of ropinirole: A mechanistic, pharmacokinetic and biochemical investigation. Int J Pharm 2012;422:436-44
88. Zhu XL, Li GF, Zeng K, et al. Preparation of lidocaine nanoemulsion and its transdermal absorption by rat skin ex vivo. Yi Ke Da Xue Xue Bao 2010;30:451-4
89. Izquierdo P, Weichers JW, Escribano E, et al. A study on the influence of emulsion droplet size on the skin penetration of tetrcaine. Skin Pharmacol Physiol 2007;20:263-70
90. Xiaoliang Z, Zhiliang C, Guofeng LI, et al. Visualization and quantification research of skin permeation of nanoemulsion. China Pharm 2007;10:17
91. Puglia C, Rizza L, Drechsler M, et al. Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: Characterization and in vitro and in vivo evaluation. Drug Deliv 2010;17:123-9
92. Zheng WW, Zhao L, Wei YM, et al. Preparation and the in vitro evaluation of nanoemulsion system for the transdermal delivery of granisetron hydrochloride. Chem Pharm Bull 2010;58:1015-19
93. Kuo F, Kutyla T, Wilson T, et al. Nanoemulsion of an anti-oxidant synergy formulation reduces tumor growth rate in neuroblastoma-bearing nude mice. J Exp Ther Oncol 2007;6:129-35
94. Kotyla T, Kuo F, Moolchandani V, et al. Increased bioavailability of transdermal application of a nano-sized emulsion preparation. Int J Pharm 2008;347:144-8
95. Yilmaz E, Borchert HH. Effect of lipid-containing positively charged nanoemulsions on skin hydration, elasticity and erythema-an in vivo study. Int J Pharm 2006;307:232-8
96. Calderilla-Fajardo SB, Cazares-Delgadillo J, Villalobos-Garcia R, et al. Influence of sucrose esters on the in vivo percutaneous penetration of octyl methoxycinammate formulated in capsules, nanoemulsions and emulsion. Drug Dev Ind Pharm 2006;32:107-13